Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea.

Jung Hyun KwonSun Hong YooSoon Woo NamHee Yeon KimChang Wook KimChan Ran YouSang Wook ChoiSe Hyun ChoJoon-Yeol HanDo Seon SongU Im ChangJin Mo YangSung Won LeeHae Lim LeeNam Ik HanSeok-Hwan KimMyeong Jun SongPil Soo SungJeong Won JangSi Hyun BaeJong Young ChoiSeung Kew Yoon

Published in: Journal of medical virology (2019)

Optimizing the choice of DAAs according to RAV test resulted in high SVR among CHC-1b Korean patients. This real practice multicenter cohort study suggests the importance of AFP and HCC surveillance in cirrhotic patients even after successful HCV therapy.

Keyphrases

hepatitis c virus
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
healthcare
prognostic factors
stem cells
human immunodeficiency virus
patient reported outcomes
clinical trial
mesenchymal stem cells
patient reported